Chemotherapy plus bevacizumab as an optimal first-line therapeutic treatment for patients with right-sided metastatic colon cancer: a meta-analysis of first-line clinical trials

por You, Xia-Hong, Jiang, Yu-Huan, Fang, Zhou, Sun, Fan, Li, Yao, Wang, Wei, Xia, Zi-Jin, Wang, Xiao-Zhong, Ying, Hou-Qun
Publicado 2020

Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients

por You, Xia-Hong, Wen, Can, Xia, Zi-Jin, Sun, Fan, Li, Yao, Wang, Wei, Fang, Zhou, Chen, Qing-Gen, Zhang, Lei, Jiang, Yu-Huang, Wang, Xiao-Zhong, Ying, Hou-Qun, Zong, Zhen
Publicado 2019